Bio-Matrix Scientific Group Inc. (BMSN.OB) Chairman Sees Future of Stem Cell Therapies Focused on Stem Cell Repositories  
9/30/2010 10:53:22 AM

SAN DIEGO, Sept. 30, 2010 (GLOBE NEWSWIRE) -- Bio-Matrix Scientific Group Inc. (OTCBB:BMSN) Chairman & CEO David Koos commented today about the future of stem cell therapy and how advances in regenerative medicine will fuel demand for stem cell repositories.